Edition:
United Kingdom

Sienna Biopharmaceuticals Inc (SNNA.OQ)

SNNA.OQ on NASDAQ Stock Exchange Global Select Market

20.04USD
20 Apr 2018
Change (% chg)

$-0.46 (-2.24%)
Prev Close
$20.50
Open
$20.46
Day's High
$20.91
Day's Low
$19.81
Volume
30,374
Avg. Vol
39,696
52-wk High
$28.95
52-wk Low
$13.37

Select another date:

Wed, Mar 21 2018

BRIEF-Sienna Biopharmaceuticals Appoints John Smither As CFO

* SIENNA BIOPHARMACEUTICALS APPOINTS JOHN W. SMITHER AS CHIEF FINANCIAL OFFICER

BRIEF-Sienna Biopharmaceuticals Qtrly Loss Per Share $0.56

* SIENNA BIOPHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Sienna Biopharmaceuticals Announces First Patient Dosed In Proof-Of-Concept Trial Of Topical By Design JAK Inhibitor SNA-125 For Atopic Dermatitis

* SIENNA BIOPHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN PROOF-OF-CONCEPT TRIAL OF TOPICAL BY DESIGN™ JAK INHIBITOR SNA-125 FOR ATOPIC DERMATITIS

BRIEF-Sienna Biopharma Announces First Patient Dosed In First-In-Human Trial Of Topical SNA-125

* SIENNA BIOPHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN FIRST-IN-HUMAN TRIAL OF TOPICAL SNA-125

BRIEF-Sienna Biopharmaceuticals posts qtrly loss per share $1.12‍​

* Sienna Biopharmaceuticals reports third quarter 2017 financial results

BRIEF-Sienna Biopharmaceuticals announces first patient dosed in phase 2B trial of topical SNA-120

* Sienna Biopharmaceuticals announces first patient dosed in phase 2B trial of topical SNA-120

Select another date: